Vaxcyte Inc (PCVX)
70.20 x 1 70.91 x 1
Pre-market by (Cboe BZX)
70.77 +2.21 (+3.22%) 03/27/25 [NASDAQ]
70.20 x 1 70.91 x 1
Pre-market 70.29 -0.48 (-0.68%) 08:39 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -463,927 | -402,266 | -223,485 | -100,077 | -89,217 |
| Depreciation Amortization | -22,859 | -24,604 | 8,506 | 4,863 | 1,405 |
| Accounts payable and accrued liabilities | 34,584 | 11,225 | 2,896 | -12,470 | 26,102 |
| Other Working Capital | -54,895 | 81,320 | 12,737 | -37,005 | 35,270 |
| Other Operating Activity | 54,470 | 37,535 | 28,749 | 23,296 | -20,188 |
| Operating Cash Flow | $-452,627 | $-296,790 | $-170,597 | $-121,393 | $-46,628 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,086,701 | -1,329,896 | -102,745 | -336,341 | N/A |
| PPE Investments | -22,427 | -16,062 | -5,841 | -6,529 | -1,105 |
| Sale Of Investment | 1,200,194 | 624,462 | 183,171 | 130,562 | N/A |
| Other Investing Activity | -96,732 | -51,815 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,005,666 | $-773,311 | $74,585 | $-212,308 | $-1,105 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 264,007 |
| Debt Repayment | N/A | N/A | N/A | N/A | -61 |
| Common Stock Issued | 2,435,656 | 636,043 | 856,480 | 3,900 | 1,045 |
| Other Financing Activity | 12,852 | 3,770 | 5,067 | 13,896 | 109,879 |
| Financing Cash Flow | $2,448,508 | $639,813 | $861,547 | $17,796 | $374,870 |
| Exchange Rate Effect | 426 | -6,686 | 137 | -439 | 87 |
| Beginning Cash Position | 398,554 | 835,528 | 69,856 | 386,200 | 58,976 |
| End Cash Position | 389,195 | 398,554 | 835,528 | 69,856 | 386,200 |
| Net Cash Flow | $-9,359 | $-436,974 | $765,672 | $-316,344 | $327,224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -452,627 | -296,790 | -170,597 | -121,393 | -46,628 |
| Capital Expenditure | -22,427 | -16,062 | -5,841 | -6,555 | -1,155 |
| Free Cash Flow | -475,054 | -312,852 | -176,438 | -127,948 | -47,783 |